BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20586904)

  • 1. Anaemia management in cardio renal disease.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    J Ren Care; 2010 May; 36 Suppl 1():86-96. PubMed ID: 20586904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome.
    Silverberg DS
    Heart Fail Rev; 2011 Nov; 16(6):609-14. PubMed ID: 20865450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anaemia in chronic heart failure].
    Hradec J
    Vnitr Lek; 2010 Aug; 56(8):854-9. PubMed ID: 20845618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS; Wexler D; Iaina A
    J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future directions in management of anemia in heart failure.
    Agarwal AK; Katz SD
    Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome.
    Palazzuoli A; Gallotta M; Iovine F; Nuti R; Silverberg DS
    Int J Clin Pract; 2008 Feb; 62(2):281-6. PubMed ID: 18081797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of correction of anaemia in patients with congestive heart failure: a short review.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Eur J Heart Fail; 2008 Sep; 10(9):819-23. PubMed ID: 18703380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of iron deficiency and anemia in cardio-renal syndromes.
    Attanasio P; Ronco C; Anker SD; Cicoira M; von Haehling S
    Semin Nephrol; 2012 Jan; 32(1):57-62. PubMed ID: 22365163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia in chronic heart failure.
    Drakos SG; Anastasiou-Nana MI; Malliaras KG; Nanas JN
    Congest Heart Fail; 2009; 15(2):87-92. PubMed ID: 19379455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
    Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
    Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin in heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
    Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists.
    Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D
    Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoiesis stimulating agents (ESAs) for congestive heart failure: the red and the black.
    Robles NR; Macias JF; Herrera J
    Eur J Intern Med; 2014 Feb; 25(2):193-6. PubMed ID: 24491240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.